Vincent et al., 2006 - Google Patents

The last 100 years of sepsis

Vincent et al., 2006

Document ID: 11306166709777905451
Author: Vincent J; Abraham E
Publication year: 2006
Publication venue: American journal of respiratory and critical care medicine

External Links

Cited by

Snippet

Over the last 100 years, huge advances have been made in the field of sepsis in terms of pathophysiology, epidemiology, diagnosis, monitoring, and therapeutics. Here, we offer our perspective of the key changes and current situation in each of these areas. Despite these …

Continue reading at www.atsjournals.org (PDF) (other versions)

238000003745 diagnosis 0 abstract description 17

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N-C(=NH)-NH2), isourea (N=C(OH)-NH2), isothiourea (-N=C(SH)-NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Similar Documents

Publication	Publication Date	Title
Vincent et al.	2006	The last 100 years of sepsis
Liu et al.	2020	Value of dynamic plasma cell-free DNA monitoring in septic shock syndrome: A case report
Malbrain et al.	2003	Effects of different body positions on intra-abdominal pressure and dynamic respiratory compliance
Jean-Louis et al.	2006	The Last 100 Years of Sepsis
Sogayar et al.	2005	What are the direct costs of sepsis treatment in Brazilian ICUs?
Tuil et al.	2003	Itraconazole IV solution in the treatment of candidemia in non-neutropenic patients
Morsch et al.	2005	Dexmedetomidine as a sedative agent for more than 24 hours in acutely ill patients
Borghi-Silva et al.	2005	Heart rate variability in the elderly with chronic obstructive pulmonary disease submitted to acute application of bi-level positive airway pressure
Bittencourt et al.	2005	Prognostic value of D-dimer in acute heart failure
Baacke et al.	2003	Kinetic therapy in Germany: results of a randomized cross-sectional survey
Silva Jr et al.	2005	Base excess and arterial lactate as early prognostic markers in severe sepsis patients
Rey et al.	2005	Validation of the ADHERE model for risk stratification in patients with acute heart failure admitted to the critical care unit
Vaisman et al.	2005	Comparison of monophasic versus biphasic cardioversion for atrial fibrillation
Carvalho et al.	2005	Mixed and central venous oxygen saturation in patients with septic shock: is there a difference?
Abdellatif et al.	2003	Iatrogenic complications in the ICU: prospective study during 10 months
Club	2005	SEPSIS IN CIRRHOSIS: REPORT ON THE
Zveibil et al.	2003	Continuous monitoring of cardiac output during pneumoperitoneum by esophagal Doppler
Sampaio et al.	2005	The use of the SOFA score to analyze the profile and severity of organ dysfunction in patients with cardiovascular disorders
Rodrigues et al.	2003	Complications of monitoring of jugular bulb venous saturation
Grion et al.	2005	Treatment of acute respiratory distress syndrome using the recommendations of the Brazilian Consensus of Sepsis in an ICU of a teaching hospital
Minkowitz et al.	2003	Efficacy and safety of a single dose of IV parecoxib sodium followed by up to 7 days of oral valdecoxib for pain following laparoscopic cholecystectomy
Eyigör et al.	2003	Additive effects of propofol and midazolam on dopamine vasodilatation of isolated rabbit renal arteries
Lescot et al.	2003	BrainView: a software designed for quantifying brain volume, weight and density
Aarts et al.	2003	Empiric antibiotic therapy for ventilator-associated pneumonia: a systematic review of the evidence
Rodigues et al.	2005	Protein losses in continuous renal replacement therapies